| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |